ComputationallyDriven Discovery of a BCR-ABL1 KinaseInhibitor with Activity in Multidrug-Resistant Chronic Myeloid Leukemia. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.